Identification, Optimal Management, and Infection Control Measures for Clostridium difficile-Associated Disease in Long-Term Care

Geriatric Nursing

Volumn 28, Issue 3, 2007, Pages 171-181

  Fletcher, Kathleen Ryan ^a   Cinalli, Marisa ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

AGED; ARTICLE; BACTERIAL INFECTION; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; EARLY DIAGNOSIS; EDUCATION; EPIDEMIC; FORECASTING; GERIATRIC ASSESSMENT; HUMAN; INFECTION CONTROL; LONG TERM CARE; NURSE ATTITUDE; NURSING ASSESSMENT; NURSING HOME; NURSING STAFF; ORGANIZATION AND MANAGEMENT; PATIENT EDUCATION; PRACTICE GUIDELINE; RECURRENT DISEASE; RISK FACTOR; STATISTICS;

AGED; ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DISEASE OUTBREAKS; EARLY DIAGNOSIS; FORECASTING; GERIATRIC ASSESSMENT; HUMANS; INFECTION CONTROL; LONG-TERM CARE; NURSE'S ROLE; NURSING ASSESSMENT; NURSING HOMES; NURSING STAFF; PATIENT EDUCATION; PRACTICE GUIDELINES; RECURRENCE; RISK FACTORS; UNIVERSAL PRECAUTIONS;

EID: 34249906769     PISSN: 01974572     EISSN: 15283984     Source Type: Journal    
DOI: 10.1016/j.gerinurse.2007.02.003     Document Type: Article

References (78)

1. Simor A.E., Bradley S.F., Strausbaugh L.J., et al., The SHEA Long-Term Care Committee. Clostridium difficile in long-term care facilities for the elderly. SHEA Position Paper. Infect Control Hosp Epidemiol 23 (2002) 696-703
2. Poutanen S.M., and Simor A.E. Clostridium difficile-associated diarrhea in adults. Can Med Assoc J 171 (2004) 51-58
3. Bartlett J.G. Antibiotic-associated diarrhea. N Engl J Med 346 (2002) 334-339
4. Mylonakis E., Ryan E.T., and Calderwood S.B. Clostridium difficile-associated diarrhea: a review. Arch Intern Med 161 (2001) 525-533
5. Bender B.S., Bennett R., Laughon B.E., et al. Is Clostridium difficile endemic in chronic-care facilities?. Lancet 2 (1986) 11-13
6. Thomas D.R., Bennett R.G., Laughon B.E., et al. Post-antibiotic colonization with Clostridium difficile in nursing home patients. J Am Geriatr Soc 38 (1990) 415-420
7. Simor A.E., Yake S.L., and Tsimidis K. Infection due to Clostridium difficile among elderly residents of a long-term-care facility. Clin Infect Dis 17 (1993) 672-678
8. Johnson S., Clabots C.R., Linn F.V., et al. Nosocomial Clostridium difficile colonisation and disease. Lancet 336 (1990) 97-100
9. Shim J.K., Johnson S., Samore M.H., et al. Primary symptomless colonization by Clostridium difficile and decreased risk of subsequent diarrhea. Lancet 351 (1998) 633-636
10. Johnson S., Homann S.R., Bettin K.M., et al. Treatment of asymptomatic Clostridium difficile carriers (fecal excretors) with vancomycin or metronidazole: a randomized, placebo-controlled trial. Ann Intern Med 117 (1992) 297-302
11. McFarland L.V., Mulligan M.E., Kwok R.Y., et al. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 320 (1989) 204-210
12. Centers for Disease Control and Prevention. Fact Sheet (2004) August (updated July 22, 2005)
13. Johnson S.J., and Gerding D.N. Clostridium difficile. In: Yu V. (Ed). Antimicrobial therapy and vaccines. 2nd ed (2002), Apple Trees Productions, New York 214
14. Warny M., Pépin J., Fang A., et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366 (2005) 1079-1084
15. Kyne L., Warny M., Qamar A., and Kelly C.P. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 342 (2000) 390-397
16. Sunenshine R.H., and McDonald L.C. Clostridium difficile-associated disease: new challenges from an established pathogen. Cleveland Clin J Med 73 (2006) 187-197
17. Bignardi G.E. Risk factors for Clostridium difficile infection. J Hosp Infect 40 (1998) 1-15
18. Gerding D.N., Olson M.M., Peterson L.R., et al. Clostridium difficile-associated diarrhea and colitis in adults: a perspective case-controlled epidemiologic study. Arch Intern Med 146 (1986) 95-100
19. Tedesco F.J., Barton R.W., and Alpers D.H. Clindamycin-associated colitis. Ann Intern Med 81 (1974) 429-433
20. Pear S., Williamson T., Bettin K., et al. Decrease in nosocomial Clostridium difficile-associated diarrhea by restricting clindamycin use. Ann Intern Med 120 (1994) 272-277
21. Linder J.A., Huang E.S., Steinman M.A., et al. Fluoroquinolone prescribing in the United States: 1995 to 2002. Am J Med 118 (2005) 259-268
22. Gaynes R., Rimland D., Killum E., et al. Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use. Clin Infect Dis 38 (2004) 640-645
23. Loo V.G., Poirier L., Miller A., et al. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N Engl J Med 353 (2005) 2442-2449
24. Pépin J., Saheb N., Coulombe M.A., et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41 (2005) 1254-1260
25. McFarland L.V., Surawicz C.M., and Stamm W.E. Risk factors for Clostridium difficile carriage and Clostridium difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis 162 (1990) 678-684
26. Thibault A., Miller M.A., and Gaese C. Risk factors for the development of Clostridium difficile-associated diarrhea during a hospital outbreak. Infect Control Hosp Epidemiol 12 (1991) 34-48
27. Kim K.H., Fekety R., Blatts D.H., et al. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis 143 (1981) 42-50
28. Pierce Jr. P.F., Wilson R., Silva Jr. J., et al. Antibiotic-associated pseudomembraneous colitis: an epidemiologic investigation of a cluster of cases. J Infect Dis 145 (1982) 269-274
29. Dial S., Delaney J.A.C., Barkun A.N., and Suissa S. Use of gastric-acid suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 294 (2005) 2989-2995
30. Pepin J., Saheb N., Coulombe M.A., et al. Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec. Clin Infect Dis 41 (2005) 1254-1260
31. Kazakova S.V., Ware K., Baughman B., et al. A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. Arch Intern Med 166 (2006) 2518-2524
32. Lowe D.O., Mamdani M.M., Kopp A., et al. Proton pump inhibitors and hospitalization for Clostridium difficile-associated disease: a population-based study. Clin Infect Dis 43 (2006) 1272-1276
33. Thorens J., Froehlich F., Schwizer W., et al. Bacterial overgrowth during treatment with omeprazole compared with cimetidine: a prospective randomised double blind study. Gut 39 (1996) 54-59
34. Gurian L., Ward T.T., and Katon R.M. Possible foodborne transmission in a case of pseudomembraneous colitis due to Clostridium difficile: influence of gastro-intestinal secretions on Clostridium difficile infection. Gastroenterology 83 (1982) 465-469
35. McDonald L.C., Owings M., and Jernigan D.B. Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003. Emerg Infect Dis 12 (2006) 409-415
36. Dallal R.M., Harbrecht B.G., Boujoukas A.J., et al. Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 235 (2002) 363-372
37. Pépin J., Valiquette L., and Cossette B. Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec. Can Med Assoc J 173 (2005) 1037-1042
38. Kutty P, Benoit S, Woods C, et al. Emerging Clostridium difficile-associated disease in the community and the role of non-antimicrobial risk factors. Abstracts of the 44th Annual Meeting of the Infectious Diseases Society of America (IDSA), October 12-15, 2006, Toronto, Ontario, Canada, P. 242 [Abstract LB-28].
39. Klein E.J., Boster D.R., Stapp J.R., et al. Diarrhea etiology in a children's hospital emergency department: a prospective cohort study. Clin Infect Dis 43 (2006) 807-813
40. McDonald L.C., Killgore G.E., Thompson A., et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 353 (2005) 2433-2441
41. Samore M., Killgore G., Johnson S., et al. Multicenter typing comparison of sporadic and outbreak Clostridium difficile isolates from geographically diverse hospitals. J Infect Dis 176 (1997) 1233-1238
42. Centers for Disease Control and Prevention. Data and Statistics about Clostridium difficile Infections. Available at: http://www.cdc.gov/ncidod/dhqp/id_Cdiff_data.html. Accessed October 2, 2006.
43. Valiquette L., Low D.E., Pépin J., and McGeer A. Clostridium difficile infection in hospitals: a brewing storm. Can Med Assoc J 171 (2004) 27-29
44. Loo V.G., Libman M.D., Miller M.A., et al. Clostridium difficile: a formidable foe. Can Med Assoc J 171 (2004) 47-48
45. Pépin J., Valiquette L., Alary M.-E., et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. Can Med Assoc J 171 (2004) 466-472
46. Muto C.A., Pokrywka M., Shutt K., et al. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect Control Hosp Epidemiol 26 (2005) 273-280
47. Bartlett J.G. Narrative review: the new epidemic of Clostridium difficile-associated enteric disease. Ann Intern Med 145 (2006) 758-764
48. Muto C.A. Poor outcomes associated with Clostridium difficile (CD)-associated diarrhea: identification and control. Management of increasingly frequent and severe Clostridium difficile-associated disease (2006) Satellite Symposium during Digestive Disease Week 2006, Los Angeles, CA, May 21
49. Wilkins T.D., and Lyerly D.M. Clostridium difficile testing: after 20 years, still challenging. J Clin Microbiol 41 (2003) 531-534
50. Gerding D.N., Johnson S., Peterson L.R., et al. Clostridium difficile-associated diarrhea and colitis. SHEA Position Paper. Infect Control Hosp Epidemiol 16 (1995) 459-477
51. Fekety R. Guidelines for the diagnosis and management of Clostridium difficile-associated diarrhea and colitis. Practice Guidelines. Am J Gastroenterol 92 (1997) 739-750
52. Aslam S., Hamill R.J., and Musher D.M. Treatment of Clostridium difficile-associated disease: old therapies and new strategies. Lancet Infect Dis 5 (2005) 549-557
53. ASHP. Therapeutic Position Statement on the preferential use of metronidazole for the treatment of Clostridium difficile-associated disease. Am J Health Syst Pharm 55 (1998) 1407-1411
54. Bartlett J.G., and Perl T.M. The new Clostridium difficile-what does it mean?. N Engl J Med 353 (2005) 2503-2505
55. Musher D.M., Aslam S., Logan N., et al. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Clin Infect Dis 40 (2005) 1586-1590
56. Pépin J., Alary M.-E., Valiquette L., et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 40 (2005) 1591-1597
57. McFarland L.V., Surawicz C.M., Greenberg R.N., et al. A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease. JAMA 271 (1994) 1913-1918
58. McFarland L.V. Alternative treatments for Clostridium difficile disease: what really works?. J Med Microbiol 54 (2005) 101-111
59. Buggy B.P., Fekety R., and Silva Jr. J. Therapy of relapsing Clostridium difficile-associated diarrhea and colitis with the combination of vancomycin and rifampin. J Clin Gastroenterol 9 (1987) 155-159
60. McFarland L.V., Elmer G.W., and Surawicz C.M. Breaking the cycle: treatment strategies for 163 cases of recurrent Clostridium difficile disease. Am J Gastroenterol 97 (2002) 1769-1775
61. Lagrotteria D., Holmes S., Smieja M., et al. Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea. Clin Infect Dis 43 (2006) 547-552
62. Surawicz C.M., McFarland L.V., Greenberg L.N., et al. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 31 (2000) 1012-1017
63. Kyne L., Warny M., Qamar A., and Kelly C.P. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 357 (2001) 189-193
64. Sougioultzis S., Kyne L., Drudy D., et al. Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea. Gastroenterology 128 (2005) 764-770
65. McPherson S., Rees C.J., Ellis R., et al. Intravenous immunoglobulin for the treatment of severe, refractory, and recurrent Clostridium difficile diarrhea. Dis Colon Rectum 49 (2006) 640-645
66. Mulligan M.E., George W.L., Rolfe R.D., et al. Epidemiologic aspects of Clostridium difficile-induced diarrhea and colitis. Am J Clin Nutr 33 (1980) 2533-2538
67. McFarland L.V., and Stamm W.E. Review of Clostridium difficile-associated diseases. Am J Infect Control 14 (1986) 99-109
68. Kramer A., Schwebke I., and Kampf G. How long do nosocomial pathogens persist on inanimate surfaces?. A systematic review. BMC Infect Dis 6 (2006) 130
69. Boyce J.M., Ligi C., Kohan C., et al. Lack of association between the increased incidence of Clostridium difficile-associated disease and the increasing use of alcohol-based hand rubs. Infect Control Hosp Epidemiol 27 (2006) 479-483
70. Loeb M., Simor A.E., Landry L., et al. Antibiotic use in Ontario facilities that provide chronic care. J Gen Intern Med 16 (2001) 376-383
71. Montgomery P., Semenchuk M., and Nicolle L.E. Antimicrobial use in nursing homes in Manitoba. J Geriatr Drug Ther 9 (1995) 55-74
72. Lee Y.L., Thrupp L.D., Lee R., et al. Infection surveillance and antibiotic utilization in a community-based skilled nursing facility. Aging Clin Exp Res 8 (1996) 113-122
73. Mylotte J.M. Measuring antibiotic use in a long-term care facility. Am J Infect Control 24 (1996) 174-179
74. Jacobson C., and Strausbaugh L.J. Incidence and impact of infection in a nursing home care unit. Am J Infect Control 18 (1990) 151-159
75. Katz P.R., Beam Jr. T.R., Brand F., et al. Antibiotic use in the nursing home. Physician practice patterns. Arch Intern Med 150 (1990) 1465-1468
76. Climo M.W., Israel D.S., Wong E.S., et al. Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost. Ann Intern Med 128 (1998) 989-995
77. O'Connor K.A., Kingston M., O'Donovan M., et al. Antibiotic prescribing policy and Clostridium difficile diarrhoea. Q J Med 97 (2004) 423-429
78. Ludlam H., Brown N., Sule O., et al. An antibiotic policy associated with reduced risk of Clostridium difficile-associated diarrhoea. Age Ageing 28 (1999) 578-580